Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Marksteiner

Showing results (41-50 of 142) with videos related to

Pageof 15
Sort By:
Current Neurovascular Research|January 6, 2015
Platelets in the Alzheimer's disease brain: do they play a role in cerebral amyloid angiopathy?Kathrin M Kniewallner, Daniela Ehrlich, Andreas Kiefer, et al.
Gerontology|April 16, 2024
Short-Term Medication Effect on Fall Risk in Multimorbid Inpatients with DementiaFranziska Podesser, Johannes Weninger, Elisabeth M Weiss, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|August 26, 2009
[Association of Mild Cognitive Impairment (MCI) and depression]Michaela Defrancesco, Josef Marksteiner, E A Deisenhammer, et al.
Neurobiology of Aging|December 18, 2019
Fear acquisition and extinction deficits in amnestic mild cognitive impairment and early Alzheimer's diseaseSarah Nasrouei, Julina A Rattel, Michael Liedlgruber, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 9, 2016
The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairmentKristaps Klavins, Therese Koal, Guido Dallmann, et al.
International Clinical Psychopharmacology|January 20, 2006
Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrationsWolfgang Aichhorn, Josef Marksteiner, Thomas Walch, et al.
The Journal of Clinical Psychiatry|April 29, 2003
Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopyUlrike Weiss, Reinhard Bacher, Herbert Vonbank, et al.
Journal of Alzheimer'S Disease : JAD|December 21, 2012
Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's diseaseMichaela Defrancesco, Josef Marksteiner, Eberhard Deisenhammer, et al.
Journal of Alzheimer'S Disease : JAD|March 9, 2017
Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?Herbert Oberacher, Kathrin Arnhard, Caroline Linhart, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2006
A widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometrySergei Mechtcheriakov, Christian Brenneis, Karl Egger, et al.
Pageof 15

Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
Current Neurovascular Research|January 6, 2015
Platelets in the Alzheimer's disease brain: do they play a role in cerebral amyloid angiopathy?Kathrin M Kniewallner, Daniela Ehrlich, Andreas Kiefer, et al.
Gerontology|April 16, 2024
Short-Term Medication Effect on Fall Risk in Multimorbid Inpatients with DementiaFranziska Podesser, Johannes Weninger, Elisabeth M Weiss, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|August 26, 2009
[Association of Mild Cognitive Impairment (MCI) and depression]Michaela Defrancesco, Josef Marksteiner, E A Deisenhammer, et al.
Neurobiology of Aging|December 18, 2019
Fear acquisition and extinction deficits in amnestic mild cognitive impairment and early Alzheimer's diseaseSarah Nasrouei, Julina A Rattel, Michael Liedlgruber, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 9, 2016
The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairmentKristaps Klavins, Therese Koal, Guido Dallmann, et al.
International Clinical Psychopharmacology|January 20, 2006
Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrationsWolfgang Aichhorn, Josef Marksteiner, Thomas Walch, et al.
The Journal of Clinical Psychiatry|April 29, 2003
Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopyUlrike Weiss, Reinhard Bacher, Herbert Vonbank, et al.
Journal of Alzheimer'S Disease : JAD|December 21, 2012
Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's diseaseMichaela Defrancesco, Josef Marksteiner, Eberhard Deisenhammer, et al.
Journal of Alzheimer'S Disease : JAD|March 9, 2017
Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?Herbert Oberacher, Kathrin Arnhard, Caroline Linhart, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2006
A widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometrySergei Mechtcheriakov, Christian Brenneis, Karl Egger, et al.
Pageof 15